IRIS
CAPURSO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.805
EU - Europa 7.598
NA - Nord America 5.385
SA - Sud America 1.483
AF - Africa 131
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.097
RU - Federazione Russa 4.856
SG - Singapore 3.049
CN - Cina 2.408
BR - Brasile 1.240
HK - Hong Kong 922
IT - Italia 810
VN - Vietnam 607
FR - Francia 404
SE - Svezia 370
DE - Germania 300
BD - Bangladesh 241
GB - Regno Unito 231
CA - Canada 134
FI - Finlandia 121
IN - India 118
AR - Argentina 104
MX - Messico 94
NL - Olanda 91
PL - Polonia 83
AT - Austria 80
ZA - Sudafrica 65
TR - Turchia 60
JP - Giappone 57
ES - Italia 55
IQ - Iraq 53
ID - Indonesia 48
EC - Ecuador 36
MD - Moldavia 33
IE - Irlanda 32
PK - Pakistan 30
UA - Ucraina 27
UZ - Uzbekistan 27
LT - Lituania 24
VE - Venezuela 24
BE - Belgio 18
PY - Paraguay 18
SA - Arabia Saudita 18
CO - Colombia 16
MY - Malesia 16
AE - Emirati Arabi Uniti 15
RO - Romania 15
UY - Uruguay 14
IL - Israele 13
MA - Marocco 13
NP - Nepal 13
PH - Filippine 13
CL - Cile 12
BH - Bahrain 11
KE - Kenya 11
TW - Taiwan 11
CR - Costa Rica 10
JM - Giamaica 10
AU - Australia 9
CH - Svizzera 9
EG - Egitto 9
JO - Giordania 9
OM - Oman 9
TN - Tunisia 9
HN - Honduras 8
IR - Iran 8
PE - Perù 8
TT - Trinidad e Tobago 7
DZ - Algeria 6
NI - Nicaragua 6
PT - Portogallo 6
TH - Thailandia 6
CZ - Repubblica Ceca 5
HU - Ungheria 5
LB - Libano 5
PS - Palestinian Territory 5
BO - Bolivia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GT - Guatemala 4
GY - Guiana 4
KR - Corea 4
KZ - Kazakistan 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
CY - Cipro 3
ET - Etiopia 3
HR - Croazia 3
KW - Kuwait 3
PA - Panama 3
SR - Suriname 3
SV - El Salvador 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GR - Grecia 2
KG - Kirghizistan 2
KH - Cambogia 2
ML - Mali 2
NG - Nigeria 2
PR - Porto Rico 2
SN - Senegal 2
Totale 22.391
Salva come PNG Salva come JPEG
Città #
Singapore 1.506
Moscow 1.036
Dallas 940
Hong Kong 908
Ashburn 820
San Jose 816
Shanghai 446
Hefei 349
Lauterbourg 302
Beijing 274
New York 244
Ho Chi Minh City 213
Milan 170
Los Angeles 160
Hanoi 146
São Paulo 126
Nuremberg 94
Santa Clara 92
Boardman 87
Munich 87
Lawrence 86
Rome 86
Princeton 85
Orem 78
Warsaw 69
Montreal 53
Tokyo 51
Johannesburg 49
Turku 48
Helsinki 47
Rio de Janeiro 46
Brooklyn 45
Atlanta 42
Council Bluffs 42
Guangzhou 41
London 39
Chicago 38
Stockholm 38
Vienna 38
Chennai 37
Frankfurt am Main 37
Denver 35
Amsterdam 34
Manchester 33
Mexico City 33
Poplar 33
Houston 32
Phoenix 32
Washington 32
Dublin 31
Seattle 31
Belo Horizonte 26
Lappeenranta 26
Da Nang 25
Boston 24
Brasília 24
Las Vegas 24
Tashkent 24
Toronto 24
Ankara 23
Brescia 21
Buffalo 21
Cesano Boscone 21
Columbus 21
Curitiba 21
Barnet 20
San Francisco 20
Shenzhen 20
The Dalles 19
Assago 18
Bologna 18
Hangzhou 18
Majano 18
Haiphong 17
Paris 17
Porto Alegre 17
Campinas 16
Minneapolis 16
Mumbai 16
Naples 16
Tianjin 16
Dhaka 15
Salvador 15
Bergamo 14
Jakarta 14
Jiaxing 14
Baghdad 13
Biên Hòa 13
Brussels 13
Miami 13
New Delhi 13
Palermo 13
Goiânia 12
Pune 12
Secaucus 12
Thái Bình 12
Verona 12
City of London 11
Florence 11
Fortaleza 11
Totale 11.087
Salva come PNG Salva come JPEG
Nome #
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 175
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 167
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 166
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 163
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 157
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 153
DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING 152
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 143
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 142
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 139
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 138
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 136
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 134
Genetic and non-genetic risk factors for early-onset pancreatic cancer 132
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 129
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 128
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 128
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 127
European evidence-based guidelines on pancreatic cystic neoplasms 126
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 124
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 123
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 123
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 121
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 120
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 119
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 119
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 119
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 117
The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls 117
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 115
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 114
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 113
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 111
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 109
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 108
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 107
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 106
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 105
Early onset pancreatic cancer. Risk factors, presentation and outcome 105
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 103
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 103
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 103
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 102
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 101
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 101
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 100
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 99
Urgent manifestations of immunoglobulin G4-related disease 99
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 99
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 97
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 96
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 96
ENDOSCOPIC ULTRASOUND (EUS)-GUIDED RADIOFREQUENCY ABLATION (RFA) OF A SYMPTOMATIC PANCREATIC INSULINOMA 95
ENDOSCOPIC ULTRASOUND-GUIDED HYBRID THERM ABLATION (EUS-HTP) IN PATIENTS (PTS) WITH LOCALLY ADVANCED (LA) PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): A CASE-CONTROL COMPARATIVE SURVIVAL ANALYSIS 95
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 94
Risk factors for the occurrence of ampullary tumors: A case-control study 94
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 94
4. Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis 94
Alcohol and gastrointestinal cancers 93
Consensus guidelines on severe acute pancreatitis 93
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 93
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 91
Activation of MNK2/eIF4E Pathway by the Splicing Factor SRSF1 Supports Pancreatic Cancer Cell Survival to Genotoxic Stress 91
Accuracy of TNM staging system in prognostic siratification of stage IV digestive endocrine tumors 90
The i-EUS consensus on the management of pancreatic fluid collections – Part 1 89
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH 87
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 87
ACUTE PANCREATITIS PATIENT REGISTRY TO EXAMINE NOVEL THERAPIES IN CLINICAL EXPERIENCE (APPRENTICE): AN INTERNATIONAL MULTICENTER CONSORTIUM FOR THE STUDY OF ACUTE PANCREATITIS 87
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study 87
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 87
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 87
The impact of nutritional status on pancreatic cancer therapy 86
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 86
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 86
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 85
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 85
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 85
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: A prospective cohort study 84
Addendum 83
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 82
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 82
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 82
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 82
Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail 82
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 82
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED STAGE. IV DIGESTIVE ENDOCRINE. TUMORS 81
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 81
Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study 80
Delay in Pancreatic Endoscopic Ultrasound during the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center 80
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 80
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 79
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 79
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 79
Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization 78
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 78
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 78
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 78
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 77
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 76
FEASIBILITY OF ORAL AND DUODENAL MICROBIOTA ANALYSIS OF PANCREATIC CANCER PATIENTS AND CONTROLS 76
Totale 10.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.787
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202269 0 0 1 29 9 2 4 3 10 3 2 6
2022/2023642 196 114 47 1 10 80 78 63 30 2 12 9
2023/20241.058 48 36 81 256 70 149 46 111 18 29 65 149
2024/20254.788 512 138 88 131 300 460 557 385 880 600 349 388
2025/202616.346 1.165 1.174 986 1.939 1.208 528 1.518 1.139 4.564 1.123 600 402
Totale 22.988